Clinical, epidemiological and metabolic characteristics in type 2 diabetics newly diagnosed with insulin as transitory therapy
Abstract
Introduction: in patients with type 2 diabetes mellitus, initial treatment with insulin is a therapeutic modality used.
Objective: to characterize clinically, epidemiologically and metabolically patients with type 2 diabetes mellitus with transient use of insulin after diagnosis.
Method: a prospective descriptive observational study was carried out in the General Provincial Teaching Hospital of Ciego de Ávila during the period from May 2015 to July 2016. From a population of 131 patients with diabetes mellitus type 2, an intentional sample of 67 was taken, which insulin was indicated transiently after diagnosis.
Results: the average age was 48,90 years. Women predominated (56,71 %) and family history (94,02 %). The mean insulin dose was 29,60 ± 6,20 Ud/day in 42,90 ± 9,3 days. There was significant improvement between the onset and six months: body mass index (30,80 ± 2,3-28,60 ± 2,06); circumference of the abdominal waist (men 108,3 ± 7,8-103,30 ± 6,20 cm and women 103,60 ± 7,10-100,10 ± 5,70 cm); fasting blood glucose (13,60 ± 1,30 mmol/L y PP2h: 22,10 ± 2,80-10 ± 0,70 mmol/L and 7,90 ± 1,10 mmol/L) and glucocylated hemoglobin (8,70 ± 1,10-6,90 ± 0,60 %). Hypoglycaemias were few: 2,90 % moderate and 5,90 % light. The almost totality was controlled with metformin at six months (92,54 %).
Conclusions: the results confirm that with the initial transient use of insulin an adequate glycemic control is achieved, subsequently maintained with metformin monotherapyDownloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Yohannys Cajigal Pelegrin, Odalys Arguelles Martínez, Maikel Roque Morgado, Eduardo Artiles Pardo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
